Earnings Call · Q2 FY2023·2023-08-03

Q2 23EPS +6.78%·Rev n/aQ1 23EPS +3.92%·Rev n/aQ4 22EPS +5.36%·Rev n/aQ3 22EPS -3.85%·Rev n/a⚠ consensus missing

GLOBUS MEDICAL INC GMED

Brian Kearns — Senior Vice President of Business Development and Investor Relations

Dan Scavilla — President and Chief Executive Officer

Keith Pfeil — Senior Vice President and Chief Financial Officer

−1.9%1d on move date−1.4% vs SPY3d−1.7%5d−2.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GMED calls or request research access.

More GMED calls Browse calls Request research access